172 related articles for article (PubMed ID: 18388377)
1. Childhood sclerodermatomyositis with generalized morphea.
Ambade GR; Dhurat RS; Lade N; Jerajani HR
Indian J Dermatol Venereol Leprol; 2008; 74(2):148-50. PubMed ID: 18388377
[TBL] [Abstract][Full Text] [Related]
2. Childhood scleromyositis with a negative PM/Scl antibody.
Marcus M; Ilyas M; Tolaymat A
Joint Bone Spine; 2010 Jan; 77(1):73-5. PubMed ID: 20022787
[TBL] [Abstract][Full Text] [Related]
3. Childhood sclerodermatomyositis: report of a case with the anti-PM/Scl antibody and mechanic's hands.
García-Patos V; Bartralot R; Fonollosa V; Arnal C; Boronat M; Gelpí C; Rodríguez JL; Castells A
Br J Dermatol; 1996 Oct; 135(4):613-6. PubMed ID: 8915158
[TBL] [Abstract][Full Text] [Related]
4. Scleroderma overlap syndromes.
Jablonska S; Blaszczyk M
Adv Exp Med Biol; 1999; 455():85-92. PubMed ID: 10599327
[TBL] [Abstract][Full Text] [Related]
5. HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap.
Wedderburn LR; McHugh NJ; Chinoy H; Cooper RG; Salway F; Ollier WE; McCann LJ; Varsani H; Dunphy J; North J; Davidson JE;
Rheumatology (Oxford); 2007 Dec; 46(12):1786-91. PubMed ID: 18003662
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies in the diagnosis of systemic rheumatic diseases.
von Mühlen CA; Tan EM
Semin Arthritis Rheum; 1995 Apr; 24(5):323-58. PubMed ID: 7604300
[TBL] [Abstract][Full Text] [Related]
7. MRI findings in deep and generalized morphea (localized scleroderma).
Horger M; Fierlbeck G; Kuemmerle-Deschner J; Tzaribachev N; Wehrmann M; Claussen CD; Fritz J
AJR Am J Roentgenol; 2008 Jan; 190(1):32-9. PubMed ID: 18094291
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous manifestations of selected rheumatologic diseases.
Ostezan LB; Callen JP
Am Fam Physician; 1996 Apr; 53(5):1625-36. PubMed ID: 8623690
[TBL] [Abstract][Full Text] [Related]
9. Localized scleroderma progressing to systemic disease. Case report and review of the literature.
Birdi N; Laxer RM; Thorner P; Fritzler MJ; Silverman ED
Arthritis Rheum; 1993 Mar; 36(3):410-5. PubMed ID: 8452586
[TBL] [Abstract][Full Text] [Related]
10. Scleroderma and dentistry: Two case reports.
Dixit S; Kalkur C; Sattur AP; Bornstein MM; Melton F
J Med Case Rep; 2016 Oct; 10(1):297. PubMed ID: 27776552
[TBL] [Abstract][Full Text] [Related]
11. Antinuclear antibodies in localized scleroderma.
Takehara K; Moroi Y; Nakabayashi Y; Ishibashi Y
Arthritis Rheum; 1983 May; 26(5):612-6. PubMed ID: 6405756
[TBL] [Abstract][Full Text] [Related]
12. A Practical Approach to Juvenile Dermatomyositis and Juvenile Scleroderma.
McCann LJ; Pain CE
Indian J Pediatr; 2016 Feb; 83(2):163-71. PubMed ID: 26489640
[TBL] [Abstract][Full Text] [Related]
13. Dermatomyositis: an association of gingival telangiectases and anti Jo-1 antibody in the adult.
Dourmishev LA; Dourmishev AL; Schwartz RA
Acta Dermatovenerol Alp Pannonica Adriat; 2007 Jun; 16(2):67-72. PubMed ID: 17992461
[TBL] [Abstract][Full Text] [Related]
14. Coexistence of morphea and systemic sclerosis.
Soma Y; Tamaki T; Kikuchi K; Abe M; Igarashi A; Takehara K; Ishibashi Y
Dermatology; 1993; 186(2):103-5. PubMed ID: 8428037
[TBL] [Abstract][Full Text] [Related]
15. Collagen Vascular Diseases: SLE, Dermatomyositis, Scleroderma, and MCTD.
Vehe RK; Riskalla MM
Pediatr Rev; 2018 Oct; 39(10):501-515. PubMed ID: 30275033
[No Abstract] [Full Text] [Related]
16. Ocular and eyelid involvement in collagen vascular diseases. Part II. Dermatomyositis, scleroderma, and sarcoidosis.
Santiago S; Enwereji N; Jiang C; Durrani K; Chaudhry S; Lu J
Clin Dermatol; 2024; 42(1):9-16. PubMed ID: 37913844
[TBL] [Abstract][Full Text] [Related]
17. Linear morphea with overlying lichen sclerosus and calcinosis cutis associated with juvenile dermatomyositis.
Kaur M; Sadhukhan S; Bhardwaj A; Patra S; Rao M; Alam A
Pediatr Dermatol; 2023; 40(3):500-502. PubMed ID: 36384242
[TBL] [Abstract][Full Text] [Related]
18. New developments in juvenile systemic and localized scleroderma.
Foeldvari I
Rheum Dis Clin North Am; 2013 Nov; 39(4):905-20. PubMed ID: 24182860
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of antinuclear antibodies in progressive systemic sclerosis].
Scagliusi P; De Lucia M; Di Luca ML; Pannarale M; Pipitone V
Minerva Med; 1984 Feb; 75(5):161-6. PubMed ID: 6366619
[TBL] [Abstract][Full Text] [Related]
20. [Spectrum of antinuclear and anti-cytoplasmic antibodies in dermatomyositis and polymyositis overlap syndromes].
Meurer M; Hausmann-Martinez-Pardo G; Braun-Falco O
Hautarzt; 1989 Oct; 40(10):623-9. PubMed ID: 2482267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
